{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:01:24Z","timestamp":1761418884219},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s11894-013-0352-2","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T10:16:42Z","timestamp":1383646602000},"source":"Crossref","is-referenced-by-count":13,"title":["Prevention of Post-ERCP Pancreatitis"],"prefix":"10.1007","volume":"15","author":[{"given":"Jennifer","family":"Maranki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Yeaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,6]]},"reference":[{"key":"352_CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gie.2008.10.039","volume":"70","author":"PB Cotton","year":"2009","unstructured":"Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80\u20138.","journal-title":"Gastrointest Endosc"},{"key":"352_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.2006.00380.x","volume":"101","author":"CL Cheng","year":"2006","unstructured":"Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139\u201347.","journal-title":"Am J Gastroenterol"},{"key":"352_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ajg.2008.5","volume":"104","author":"P Wang","year":"2009","unstructured":"Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104:31\u201340.","journal-title":"Am J Gastroenterol"},{"key":"352_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(98)70121-X","volume":"48","author":"S Loperfido","year":"1998","unstructured":"Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1\u201310.","journal-title":"Gastrointest Endosc"},{"key":"352_CR5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.giec.2012.05.001","volume":"22","author":"ML Freeman","year":"2012","unstructured":"Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointest Endosc Clin N Am. 2012;22:567\u201386.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"352_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","volume":"37","author":"PB Cotton","year":"1991","unstructured":"Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383\u201393.","journal-title":"Gastrointest Endosc"},{"key":"352_CR7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2012.12.043","volume":"144","author":"MM Lerch","year":"2013","unstructured":"Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis. Gastroenterology. 2013;144:1180\u201393.","journal-title":"Gastroenterology"},{"key":"352_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mge.2001.117550","volume":"54","author":"ML Freeman","year":"2001","unstructured":"Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425\u201334.","journal-title":"Gastrointest Endosc"},{"key":"352_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","volume":"335","author":"ML Freeman","year":"1996","unstructured":"Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909\u201318.","journal-title":"N Engl J Med"},{"key":"352_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","volume":"96","author":"E Masci","year":"2001","unstructured":"Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417\u201323.","journal-title":"Am J Gastroenterol"},{"key":"352_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1055\/s-2007-966723","volume":"39","author":"EJ Williams","year":"2007","unstructured":"Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007;39:793\u2013801.","journal-title":"Endoscopy"},{"key":"352_CR12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1055\/s-2003-42614","volume":"35","author":"E Masci","year":"2003","unstructured":"Masci E, Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35:830\u20134.","journal-title":"Endoscopy"},{"key":"352_CR13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0016-5107(02)70112-0","volume":"56","author":"J Vandervoort","year":"2002","unstructured":"Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56:652\u20136.","journal-title":"Gastrointest Endosc"},{"key":"352_CR14","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/ajg.2010.136","volume":"105","author":"PA Testoni","year":"2010","unstructured":"Testoni PA, Mariani A, Giussani A, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010;105:1753\u201361.","journal-title":"Am J Gastroenterol"},{"key":"352_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.giec.2012.12.007","volume":"23","author":"B Balmadrid","year":"2013","unstructured":"Balmadrid B, Kozarek R. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am. 2013;23:385\u2013403.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"352_CR16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10620-010-1317-z","volume":"56","author":"N Banerjee","year":"2011","unstructured":"Banerjee N, Hilden K, Baron TH, et al. Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci. 2011;56:591\u20135.","journal-title":"Dig Dis Sci"},{"key":"352_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0029-1243992","volume":"42","author":"V Cennamo","year":"2010","unstructured":"Cennamo V, Fuccio L, Zagari RM, et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy. 2010;42:381\u20138.","journal-title":"Endoscopy"},{"key":"352_CR18","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1007\/s00464-010-1033-y","volume":"24","author":"B Gong","year":"2010","unstructured":"Gong B, Hao L, Bie L, et al. Does precut technique improve selective bile duct cannulation or increase post-ERCP pancreatitis rate? A meta-analysis of randomized controlled trials. Surg Endosc. 2010;24:2670\u201380.","journal-title":"Surg Endosc"},{"key":"352_CR19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.dld.2011.05.010","volume":"43","author":"PA Testoni","year":"2011","unstructured":"Testoni PA, Giussani A, Vailati C, et al. Precut sphincterotomy, repeated cannulation and post-ERCP pancreatitis in patients with bile duct stone disease. Dig Liver Dis. 2011;43:792\u20136.","journal-title":"Dig Liver Dis"},{"key":"352_CR20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1053\/j.gastro.2004.07.017","volume":"127","author":"JA Disario","year":"2004","unstructured":"Disario JA, Freeman ML, Bjorkman DJ, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127:1291\u20139.","journal-title":"Gastroenterology"},{"key":"352_CR21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00535-006-1969-9","volume":"42","author":"H Watanabe","year":"2007","unstructured":"Watanabe H, Yoneda M, Tominaga K, et al. Comparison between endoscopic papillary balloon dilatation and endoscopic sphincterotomy for the treatment of common bile duct stones. J Gastroenterol. 2007;42:56\u201362.","journal-title":"J Gastroenterol"},{"key":"352_CR22","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s10620-012-2494-8","volume":"58","author":"SJ Park","year":"2013","unstructured":"Park SJ, Kim JH, Hwang JC, et al. Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci. 2013;58:1100\u20139.","journal-title":"Dig Dis Sci"},{"key":"352_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.dld.2012.10.015","volume":"45","author":"GA Paspatis","year":"2013","unstructured":"Paspatis GA, Konstantinidis K, Tribonias G, et al. Sixty- versus thirty-seconds papillary balloon dilation after sphincterotomy for the treatment of large bile duct stones: a randomized controlled trial. Dig Liver Dis. 2013;45:301\u20134.","journal-title":"Dig Liver Dis"},{"key":"352_CR24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.gie.2009.08.007","volume":"70","author":"J Cheung","year":"2009","unstructured":"Cheung J, Tsoi KK, Quan WL, et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2009;70:1211\u20139.","journal-title":"Gastrointest Endosc"},{"key":"352_CR25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1477-2574.2008.00020.x","volume":"11","author":"H Matsubayashi","year":"2009","unstructured":"Matsubayashi H, Fukutomi A, Kanemoto H, et al. Risk of pancreatitis after endoscopic retrograde cholangiopancreatography and endoscopic biliary drainage. HPB (Oxford). 2009;11:222\u20138.","journal-title":"HPB (Oxford)"},{"key":"352_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0030-1256194","volume":"43","author":"T Meister","year":"2011","unstructured":"Meister T, Heinzow H, Heinecke A, et al. Post-ERCP pancreatitis in 2364 ERCP procedures: is intraductal ultrasonography another risk factor? Endoscopy. 2011;43:331\u20136.","journal-title":"Endoscopy"},{"key":"352_CR27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.gie.2010.05.023","volume":"72","author":"GA Cote","year":"2010","unstructured":"Cote GA, Kumar N, Ansstas M, et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc. 2010;72:748\u201354.","journal-title":"Gastrointest Endosc"},{"key":"352_CR28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gie.2005.11.052","volume":"63","author":"C Soderlund","year":"2006","unstructured":"Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc. 2006;63:986\u201395.","journal-title":"Gastrointest Endosc"},{"key":"352_CR29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.gie.2007.06.057","volume":"67","author":"M Kahaleh","year":"2008","unstructured":"Kahaleh M, Behm B, Clarke BW, et al. Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest Endosc. 2008;67:446\u201354.","journal-title":"Gastrointest Endosc"},{"key":"352_CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.2003.018945","volume":"53","author":"H Isayama","year":"2004","unstructured":"Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of \u201ccovered\u201d versus \u201cuncovered\u201d diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729\u201334.","journal-title":"Gut"},{"key":"352_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ctrv.2006.10.006","volume":"33","author":"AC Moss","year":"2007","unstructured":"Moss AC, Morris E, Leyden J, et al. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33:213\u201321.","journal-title":"Cancer Treat Rev"},{"key":"352_CR32","first-page":"654","volume":"91","author":"A Schmassmann","year":"1996","unstructured":"Schmassmann A, von Gunten E, Knuchel J, et al. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol. 1996;91:654\u20139.","journal-title":"Am J Gastroenterol"},{"key":"352_CR33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.gie.2005.11.054","volume":"63","author":"WJ Yoon","year":"2006","unstructured":"Yoon WJ, Lee JK, Lee KH, et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2006;63:996\u20131000.","journal-title":"Gastrointest Endosc"},{"key":"352_CR34","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s10620-012-2482-z","volume":"58","author":"AA Siddiqui","year":"2013","unstructured":"Siddiqui AA, Mehendiratta V, Loren D, et al. Self-Expanding Metal Stents (SEMS) for Preoperative Biliary Decompression in Patients with Resectable and Borderline-Resectable Pancreatic Cancer: Outcomes in 241 Patients. Dig Dis Sci. 2013;58:1744\u201350.","journal-title":"Dig Dis Sci"},{"key":"352_CR35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0016-5107(04)00363-3","volume":"59","author":"F Lella","year":"2004","unstructured":"Lella F, Bagnolo F, Colombo E, et al. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc. 2004;59:830\u20134.","journal-title":"Gastrointest Endosc"},{"key":"352_CR36","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1440-1746.2009.06010.x","volume":"24","author":"LM Shao","year":"2009","unstructured":"Shao LM, Chen QY, Chen MY, et al. Can wire-guided cannulation reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis? A meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2009;24:1710\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"352_CR37","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/MCG.0b013e3181aacbd1","volume":"44","author":"DG Adler","year":"2010","unstructured":"Adler DG, Verma D, Hilden K, et al. Dye-free wire-guided cannulation of the biliary tree during ERCP is associated with high success and low complication rates: outcomes in a single operator experience of 822 cases. J Clin Gastroenterol. 2010;44:e57\u201362.","journal-title":"J Clin Gastroenterol"},{"key":"352_CR38","first-page":"149","volume":"20","author":"A Trifan","year":"2011","unstructured":"Trifan A, Sfarti C, Cretu M, et al. Guide-wire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis in patients with choledocholithiasis. J Gastrointest Liver Dis. 2011;20:149\u201352.","journal-title":"J Gastrointest Liver Dis"},{"key":"352_CR39","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1440-1746.2011.06788.x","volume":"26","author":"Y Nakai","year":"2011","unstructured":"Nakai Y, Isayama H, Tsujino T, et al. Impact of introduction of wire-guided cannulation in therapeutic biliary endoscopic retrograde cholangiopancreatography. J Gastroenterol Hepatol. 2011;26:1552\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"352_CR40","doi-asserted-by":"crossref","unstructured":"\u2022 Tse F, Yuan Y, Moayyedi P, et al. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database Syst Rev. 2012;12, CD009662. This meta-analysisdemonstrated that guidewire-assisted cannulation was associated with a significantly decreasedrisk of PEP when compared to contrast-assisted cannulation.","DOI":"10.1002\/14651858.CD009662"},{"key":"352_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gie.2010.10.039","volume":"73","author":"A Choudhary","year":"2011","unstructured":"Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73:275\u201382.","journal-title":"Gastrointest Endosc"},{"key":"352_CR42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-0030-1255781","volume":"42","author":"T Mazaki","year":"2010","unstructured":"Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2010;42:842\u201353.","journal-title":"Endoscopy"},{"key":"352_CR43","doi-asserted-by":"crossref","unstructured":"Mazaki T, Mado K, Masuda H, et al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol 2013. doi: 10.1007\/s00535-013-0806-1 .","DOI":"10.1007\/s00535-013-0806-1"},{"key":"352_CR44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0016-5107(03)02530-6","volume":"59","author":"ML Freeman","year":"2004","unstructured":"Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004;59:8\u201314.","journal-title":"Gastrointest Endosc"},{"key":"352_CR45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2011.06.033","volume":"9","author":"A Sofuni","year":"2011","unstructured":"Sofuni A, Maguchi H, Mukai T, et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol. 2011;9:851\u20138. quiz e110.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"352_CR46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0016-5107(90)70958-3","volume":"36","author":"RA Kozarek","year":"1990","unstructured":"Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc. 1990;36:93\u20135.","journal-title":"Gastrointest Endosc"},{"key":"352_CR47","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1055\/s-0029-1215317","volume":"41","author":"YG Bakman","year":"2009","unstructured":"Bakman YG, Safdar K, Freeman ML. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy. 2009;41:1095\u20138.","journal-title":"Endoscopy"},{"key":"352_CR48","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1007\/s10620-011-1695-x","volume":"56","author":"A Pahk","year":"2011","unstructured":"Pahk A, Rigaux J, Poreddy V, et al. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate. Dig Dis Sci. 2011;56:3058\u201364.","journal-title":"Dig Dis Sci"},{"key":"352_CR49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.gie.2012.05.001","volume":"76","author":"TH Lee","year":"2012","unstructured":"Lee TH, Moon JH, Choi HJ, et al. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Gastrointest Endosc. 2012;76:578\u201385.","journal-title":"Gastrointest Endosc"},{"key":"352_CR50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0030-1256305","volume":"43","author":"E Zolotarevsky","year":"2011","unstructured":"Zolotarevsky E, Fehmi SM, Anderson MA, et al. Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial. Endoscopy. 2011;43:325\u201330.","journal-title":"Endoscopy"},{"key":"352_CR51","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1572-0241.2007.01165.x","volume":"102","author":"R Sotoudehmanesh","year":"2007","unstructured":"Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol. 2007;102:978\u201383.","journal-title":"Am J Gastroenterol"},{"key":"352_CR52","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1440-1746.2007.05096.x","volume":"23","author":"M Khoshbaten","year":"2008","unstructured":"Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol. 2008;23:e11\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"352_CR53","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","volume":"124","author":"B Murray","year":"2003","unstructured":"Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2003;124:1786\u201391.","journal-title":"Gastroenterology"},{"key":"352_CR54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/gut.2007.140756","volume":"57","author":"BJ Elmunzer","year":"2008","unstructured":"Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262\u20137.","journal-title":"Gut"},{"key":"352_CR55","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.gie.2012.08.021","volume":"76","author":"X Ding","year":"2012","unstructured":"Ding X, Chen M, Huang S, et al. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc. 2012;76:1152\u20139.","journal-title":"Gastrointest Endosc"},{"key":"352_CR56","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00535-012-0554-7","volume":"47","author":"T Otsuka","year":"2012","unstructured":"Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47:912\u20137.","journal-title":"J Gastroenterol"},{"key":"352_CR57","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414\u201322. This study showed that the use of rectal in domethacin significantly reduced the risk of post-ERCP pancreatitis in high-risk patients.","DOI":"10.1056\/NEJMoa1111103"},{"key":"352_CR58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ajg.2012.442","volume":"108","author":"BJ Elmunzer","year":"2013","unstructured":"Elmunzer BJ, Higgins PD, Saini SD, et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013;108:410\u20135.","journal-title":"Am J Gastroenterol"},{"key":"352_CR59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0016-5107(02)70178-8","volume":"56","author":"F Prat","year":"2002","unstructured":"Prat F, Amaris J, Ducot B, et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc. 2002;56:202\u20138.","journal-title":"Gastrointest Endosc"},{"key":"352_CR60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0016-5107(03)02540-9","volume":"59","author":"JJ Schwartz","year":"2004","unstructured":"Schwartz JJ, Lew RJ, Ahmad NA, et al. The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc. 2004;59:179\u201384.","journal-title":"Gastrointest Endosc"},{"key":"352_CR61","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1440-1746.2011.06718.x","volume":"26","author":"LH Xu","year":"2011","unstructured":"Xu LH, Qian JB, Gu LG, et al. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla. J Gastroenterol Hepatol. 2011;26:1139\u201344.","journal-title":"J Gastroenterol Hepatol"},{"key":"352_CR62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00535-008-2272-8","volume":"44","author":"M Matsushita","year":"2009","unstructured":"Matsushita M, Takakuwa H, Shimeno N, et al. Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol. 2009;44:71\u20135.","journal-title":"J Gastroenterol"},{"key":"352_CR63","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0029-1214951","volume":"41","author":"Y Bai","year":"2009","unstructured":"Bai Y, Xu C, Yang X, et al. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials. Endoscopy. 2009;41:690\u20135.","journal-title":"Endoscopy"},{"key":"352_CR64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-230X-10-85","volume":"10","author":"B Chen","year":"2010","unstructured":"Chen B, Fan T, Wang CH. A meta-analysis for the effect of prophylactic GTN on the incidence of post-ERCP pancreatitis and on the successful rate of cannulation of bile ducts. BMC Gastroenterol. 2010;10:85.","journal-title":"BMC Gastroenterol"},{"key":"352_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10620-008-0709-9","volume":"55","author":"LM Shao","year":"2010","unstructured":"Shao LM, Chen QY, Chen MY, et al. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci. 2010;55:1\u20137.","journal-title":"Dig Dis Sci"},{"key":"352_CR66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MPA.0b013e3181f94d46","volume":"40","author":"KS Yoo","year":"2011","unstructured":"Yoo KS, Huh KR, Kim YJ, et al. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial. Pancreas. 2011;40:181\u20136.","journal-title":"Pancreas"},{"key":"352_CR67","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.gie.2007.02.055","volume":"65","author":"G Manes","year":"2007","unstructured":"Manes G, Ardizzone S, Lombardi G, et al. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc. 2007;65:982\u20137.","journal-title":"Gastrointest Endosc"},{"key":"352_CR68","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/MPA.0b013e31822116d5","volume":"40","author":"KT Park","year":"2011","unstructured":"Park KT, Kang DH, Choi CW, et al. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas. 2011;40:1215\u20139.","journal-title":"Pancreas"},{"key":"352_CR69","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.gie.2010.09.022","volume":"73","author":"T Seta","year":"2011","unstructured":"Seta T, Noguchi Y. Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest Endosc. 2011;73:700\u20136. e1-2.","journal-title":"Gastrointest Endosc"},{"key":"352_CR70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5009\/gnl.2012.6.2.256","volume":"6","author":"YW Yoo","year":"2012","unstructured":"Yoo YW, Cha SW, Kim A, et al. The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Gut Liver. 2012;6:256\u201361.","journal-title":"Gut Liver"},{"key":"352_CR71","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MPA.0b013e3182152eb6","volume":"40","author":"PS Jowell","year":"2011","unstructured":"Jowell PS, Branch MS, Fein SH, et al. Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography. Pancreas. 2011;40:533\u20139.","journal-title":"Pancreas"},{"key":"352_CR72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPA.0b013e31816c90a1","volume":"37","author":"Y Bai","year":"2008","unstructured":"Bai Y, Gao J, Zou DW, et al. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Pancreas. 2008;37:241\u20136.","journal-title":"Pancreas"},{"key":"352_CR73","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2006.10.030","volume":"65","author":"A Andriulli","year":"2007","unstructured":"Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007;65:624\u201332.","journal-title":"Gastrointest Endosc"},{"key":"352_CR74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0031-1291440","volume":"44","author":"P Katsinelos","year":"2012","unstructured":"Katsinelos P, Fasoulas K, Paroutoglou G, et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy. 2012;44:53\u20139.","journal-title":"Endoscopy"},{"key":"352_CR75","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MEG.0b013e328351097f","volume":"24","author":"S Li","year":"2012","unstructured":"Li S, Cao G, Chen X, et al. Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2012;24:477\u201381.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"352_CR76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.gie.2011.04.047","volume":"74","author":"HC Oh","year":"2011","unstructured":"Oh HC, Cheon YK, Cho YD, et al. Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial. Gastrointest Endosc. 2011;74:556\u201362.","journal-title":"Gastrointest Endosc"},{"key":"352_CR77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2891-12-23","volume":"12","author":"WJ Gu","year":"2013","unstructured":"Gu WJ, Wei CY, Yin RX. Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Nutr J. 2013;12:23.","journal-title":"Nutr J"},{"key":"352_CR78","doi-asserted-by":"crossref","unstructured":"Tsujino T, Isayama H, Nakai Y, et al. The results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis with Risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial. J Gastroenterol. 2013;48(8):982\u20138.","DOI":"10.1007\/s00535-012-0698-5"},{"key":"352_CR79","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000151999","volume":"8","author":"Y Bai","year":"2008","unstructured":"Bai Y, Gao J, Shi X, et al. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology. 2008;8:504\u20139.","journal-title":"Pancreatology"},{"key":"352_CR80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MPA.0b013e31819777d5","volume":"38","author":"S Sherman","year":"2009","unstructured":"Sherman S, Cheng CL, Costamagna G, et al. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. Pancreas. 2009;38:267\u201374.","journal-title":"Pancreas"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-013-0352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-013-0352-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-013-0352-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T01:04:15Z","timestamp":1564621455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-013-0352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1007\/s11894-013-0352-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]},"article-number":"352"}}